Cellvizio by Mauna Kea Technologies

Cellvizio by Mauna Kea Technologies Cellvizio is the real-time in vivo cellular imaging platform that revolutionizes the way physicians

Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine.

10/09/2025

often begins as small nodules making early and accurate diagnosis crucial for improving treatment outcomes and increasing survival rates.

Learn how Professor Stéphane Renaud and his team at the CHRU de Nancy are leveraging to transform patient care: https://hubs.la/Q03MWtNn0

An early & accurate diagnosis of lung nodules allows timely surgical resection of malignancy while avoiding unnecessary ...
10/08/2025

An early & accurate diagnosis of lung nodules allows timely surgical resection of malignancy while avoiding unnecessary surgery. For , take a moment to learn how Cellvizio can capture images from inside a lung lesion in real time, in vivo, providing the advantage of unique visibility and information: https://hubs.la/Q03MCysm0

Pancreatic cystic lesions are increasingly found, and accurate diagnosis is key to the right treatment path. A recent ca...
09/30/2025

Pancreatic cystic lesions are increasingly found, and accurate diagnosis is key to the right treatment path. A recent case underscores EUS-nCLE's ( ) potential to identify unique imaging patterns that can differentiate rare benign lesions from those requiring surgery, especially when other diagnostic markers might be misleading, thereby guiding more appropriate patient management.

Read more: https://hubs.la/Q03LvPDB0

09/25/2025

offers unprecedented cellular-level visualization, empowering physicians to understand and treat patients with greater precision unlike any other platform available today. This groundbreaking technology is transforming the landscape of healthcare.

Discover Cellvizio's transformative impact: https://hubs.la/Q03KVFs90

We hosted our workshop on diagnostics, expertly led by Pr. Stéphane Renaud, MD, PhD at CHRU de Nancy. Workshop highlig...
09/25/2025

We hosted our workshop on diagnostics, expertly led by Pr. Stéphane Renaud, MD, PhD at CHRU de Nancy. Workshop highlights included clinical cases using to target the optimal surgical site when malignant nodules were present, and hands-on learning for student assistants.

Thank you to Professor Renaud and all participants for making this educational event a success!

09/19/2025

has been officially included in the Australian Register of Therapeutic Goods (Therapeutic Goods Administration - TGA).

This milestone marks a significant step in our global expansion and establishes our presence in the Australian market. The collaboration with Endotherapeutics is a key part of our strategy to accelerate the commercial deployment of Cellvizio and the program in this region.

Read the full PR: https://hubs.la/Q03K4F0b0

We had a great time at ! So much groundbreaking research and thought-provoking discussions on .DGVS - Deutsche Gesells...
09/18/2025

We had a great time at ! So much groundbreaking research and thought-provoking discussions on .

DGVS - Deutsche Gesellschaft für Gastroenterologie

A huge thank you to everyone who attended ! It was an incredible success, filled with insightful discussions, valuable ...
09/16/2025

A huge thank you to everyone who attended ! It was an incredible success, filled with insightful discussions, valuable connections, and inspiring presentations. We'd like to express our sincere gratitude to Dan Lister, MD FACS FAFS for exceptional leadership and dedication during your time as President.

A special thanks to Kate Freeman for the tireless work in organizing this successful event. Your efforts made a significant impact.

See you all next year!

American Foregut Society

Join us at and get up close with the revolutionary next-generation platform in person! Visit our booth for a hands-o...
09/11/2025

Join us at and get up close with the revolutionary next-generation platform in person! Visit our booth for a hands-on experience!

American Foregut Society

Cellvizio by Mauna Kea Technologies is excited to attend the 2025 American Foregut Society Annual Meeting from September...
09/09/2025

Cellvizio by Mauna Kea Technologies is excited to attend the 2025 American Foregut Society Annual Meeting from September 11th through 14th! Catch us at Booth 19.

We’re looking forward to connecting with the foregut community and supporting innovation in care. Don't miss it: https://hubs.la/Q03HpVvn0

09/08/2025

Today we announce the American Foregut Society (AFS) has strongly advocated via an open letter highlighting Cellvizio’s superiority to conventional tools for detecting pre-cancerous tissue. This advocacy reflects the society’s recognition that despite overwhelming clinical evidence supporting Cellvizio, coverage limitations have prevented many patients from accessing the most accurate diagnostic evaluation available.

Read the full PR: https://hubs.la/Q03HnCYj0

Read the letter: https://hubs.la/Q03HnFyc0

09/04/2025

We are pleased to announce a premier educational meeting on the endomicroscopic diagnosis of food intolerance with , happening alongside UEG - United European Gastroenterology in Berlin.

This is a must-attend event for gastroenterologists, dietitians, nutritionists, and researchers. Join us to explore the cutting-edge application of endomicroscopy in diagnosing and managing food intolerances in patients.

For full details visit:
https://hubs.la/Q03GVBw00

RSVP: https://hubs.la/Q03GVwDg0

Address

24 Denby Road, Suite 140
Boston, MA
02134

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Cellvizio by Mauna Kea Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product, Cellvizio®, has received clearance/approval in a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico.